ProMIS Neurosciences, Inc. (PMN)

11.53 -0.31 (-2.62%) USD  |  NASDAQ  |  Apr 17, 16:00
11.28 -0.25 (-2.17%) After-Hours: 20:00
More

ProMIS Neurosciences Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for PMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Oncolytics Biotech, Inc. --
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade